US Seniors And OTCs For Chronic Pain Relief

5 August 1997

Among the USA's senior citizens, 51% who take over-the-counter drugs forchronic pain conditions said they take an OTC pain reliever daily and 17% said they use one "several times a week," according to a new study by the National Council on the Aging. 32% said they used such products "rarely," and 17% that they used them "several times a month," with 15% "less often than that." The study was conducted among 500 seniors aged 60 or more who in the past five years had a pain condition that lasted for six months or longer and who had taken a pain medicine on a regular basis as recommended or prescribed by their physician to manage their pain conditions.

Also noted in the study, which was carried out for the NCOA by Louis Harris & Associates, is that nearly 75% of seniors who take prescription pain relievers for their conditions take OTC analgesics as well. 85% of those who take OTC pain drugs say they are effective.

- The US Consumer Product Safety Commission has asked the US Nonprescription Drug Manufacturers Association to remind its members that the 18-month blanket exemption from compliance with the new senior-adult requirement for child-resistant packaging will expire on January 21, 1998.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight